Traphaco Joint Stock Co (coded TRA) has announced to finish purchasing 317,104 shares of Dak Lak Pharmaceutical and Medical Instrument Joint Stock Co (Duoc Dak Lak) at price of 25,000 dong per share. Those shares accounted for 24.5 percent of Duoc Dak Lak’s total chartered capital.
This year, Traphaco plans to spend 17 billion dong purchasing 51 percent of the total stake in Duoc Dak Lak. If the transaction ends successfully, the company would keep majority holdings in Dak Lak Pharmaceutical Co.
Vu Thi Thuan, Traphaco’s chair of management board revealed that in the near future, her company would acquire additional 2-3 more firms so as to develop the distribution network and supplement the raw material sources for Traphaco.
With chartered capital of 12.9 billion dong, Duoc Dak Lak has major business lines of distributing the pharmaceutical products. Last year, the company reported gaining revenue of 270 billion dong and profit of 5 billion dong.